Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07537400
Recruiting
Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5
Phase 2 · Israel · 1 site
Registry update: 17 Sept 2026
NCT07468344
Recruiting
Evaluation of the Effects of Sauna Therapy on Congestion and Loop Diuretic Use in Patients With Heart Failure With Reduced or Moderately Reduced Ejection Fraction
Not applicable · France · 1 site
Registry update: 29 Oct 2026
NCT07861035
Recruiting
A Phase I Study of Allogeneic Myocardium-Derived Mesenchymal Stem Cells (HB1011) in Patients With Ischemic Cardiomyopathy
Phase 1 · South Korea · 1 site
Registry update: 6 Oct 2026
NCT07634471
Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Phase 2/3 · Argentina, Australia, Chile, China, Germany, Spain, France, Greece, Israel, Italy, South Korea, Poland, Taiwan, United States · 39 sites
Registry update: 26 Oct 2026
NCT07314216
Recruiting
Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
Phase 2 · China · 1 site
Registry update: 8 Jul 2026
NCT07434739
Recruiting
PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies
Not applicable · France · 1 site
Registry update: 14 Sept 2026
NCT07380113
Recruiting
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
Phase 4 · China · 1 site
Registry update: 25 Aug 2026
NCT07647250
Recruiting
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
Not applicable · United States · 1 site
Registry update: 24 Jun 2026
NCT07751445
Recruiting
Unilateral and Bilateral Resistance Training in Hypertension
Not applicable · 1 site
Registry update: 7 Aug 2026
2025-524894-17-00
Recruiting
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Phase 2/3 · Austria, Czechia, Denmark, Spain, France, Croatia, Hungary, Italy, Portugal, Slovakia · 55 sites
Registry update: 10 Sept 2026
NCT07602777
Recruiting
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Phase 1/2 · Canada, France, United Kingdom, Israel, Japan, United States · 13 sites
Registry update: 1 Oct 2026
2025-521390-14-00
Recruiting
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
Phase 2 · Austria, Czechia, Germany, Denmark, Italy, Netherlands, Poland, Sweden · 22 sites
Registry update: 4 Aug 2026
NCT07691606
Recruiting
A Study of ARC-02 in B-cell NHL
Phase 1 · Australia, Spain, France, Italy, Poland, United States · 28 sites
Registry update: 2 Nov 2026
NCT06995625
Recruiting
The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA)
Phase 1 · South Korea · 3 sites
Registry update: 6 Jul 2026
NCT07659821
Recruiting
Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies
Not applicable · United States · 3 sites
Registry update: 30 Jun 2026
NCT07593248
Recruiting
Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
Not applicable · China · 13 sites
Registry update: 13 Aug 2026
NCT07552610
Recruiting
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
Not applicable · China · 2 sites
Registry update: 25 Jun 2026
NCT07379190
Recruiting
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
Phase 3 · China · 1 site
Registry update: 25 Jun 2026
NCT07675590
Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Phase 1 · United States · 1 site
Registry update: 2 Oct 2026
NCT07843927
Recruiting
Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.
Phase 3 · Germany · 8 sites
Registry update: 28 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.